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Abstract 
Nontypeable Haemophilus influenzae (NTHi) is the most common pathogen in 
primary ciliary dyskinesia (PCD) patients. We hypothesized that abnormal ciliary motility and 
low airway nitric oxide (NO) levels on airway epithelial cells from PCD patients might be 
permissive for NTHi colonization and biofilm development. We used a primary epithelial cell 
co-culture model to investigate NTHi infection. 
Primary airway epithelial cells from PCD and non-PCD patients were differentiated to 
ciliation using air-liquid interface culture and then co-cultured with NTHi. NTHi adherence 
was greater on PCD epithelial cells compared to non-PCD cells (P<0.05) and the distribution 
of NTHi on PCD epithelium showed more aggregated NTHi in biofilms (P<0.001). Apart from 
defective ciliary motility, PCD cells did not significantly differ from non-PCD epithelial cells in 
the degree of ciliation and epithelial integrity or in cytokine, LL-37 and NO production. 
Treatment of PCD epithelia using exogenous NO and antibiotic significantly reduced NTHi 
viability in biofilms compared to antibiotic treatment alone. 
Impaired ciliary function was the primary defect in PCD airway epithelium underlying 
susceptibility to NTHi biofilm development compared with non-PCD epithelium. Although 
NO responses were similar, use of targeted NO with antibiotics enhanced killing of NTHi in 
biofilms, suggesting a novel therapeutic approach. 
 
 
 
Introduction 
 
Motile cilia in the airway contribute to mucociliary clearance (MCC), which is fundamental 
for protecting the host from respiratory infection.  Primary ciliary dyskinesia (PCD) is a 
genetically heterogeneous condition characterised by abnormal ciliary function with 
compromised MCC. Patients are characterised by recurrent and chronic sinopulmonary 
infection, chronic otitis media (OM) and progressive suppurative lung disease from a young 
age [1].  
 
Non-typeable Haemophilus influenzae (NTHi) is a Gram-negative coccobacillus and, with 
pneumococcus, the most common bacterial pathogen isolated from the upper and lower 
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respiratory tract of pediatric patients with PCD [2] and chronic OM [3].  NTHi biofilms are 
present in vivo [4], [5] and ex vivo on adenoid epithelium, or middle ear epithelial biopsies 
from children with OM [6], [7].  
 
Biofilms are self-organising aggregates of bacteria enveloped in an exopolymeric matrix 
associated with the respiratory mucosal surface [8], [9], [10] and are present in chronic 
upper and lower respiratory tract infections in OM [6], cystic fibrosis (CF) [11], chronic 
rhinosinusitis [12] and non-CF bronchiectasis [13].  Biofilm development contributes to the 
pathophysiology of chronic suppurative respiratory diseases by increasing bacterial 
recalcitrance to antibiotic therapy and host innate immune responses [14], [15].  Although 
the effects of abnormal ciliary function on respiratory infections have been studied in 
animal models of bacterial-virus co-infection [16], [17], bacterial infection has not been 
widely studied in PCD.  
 
For reasons that are not understood, patients with PCD have low airway nitric oxide (NO) 
levels compared to non-PCD patients [18], [19].  NO, produced by host epithelial cells and 
innate immune cells, can be low in response to infection with some respiratory bacteria 
[20], [21]. We previously observed no difference in the mean NO levels of uninfected 
primary cultured PCD and non-PCD epithelia, consistent with baseline NO levels reported by 
others [20], [22].  However we found PCD epithelial cells significantly increased NO 
production in response to either stimulation with pro-inflammatory cytokines or to NTHi 
infection, similar to non-PCD cells [22]. Given the susceptibility of children with PCD to 
airway infection with NTHi, we hypothesized that epithelial cells from patients with PCD 
might be permissive for increased NTHi adherence and subsequent biofilm development. To 
address this hypothesis, we developed a human primary co-culture model using ciliated PCD 
or non-PCD airway epithelial cells, differentiated at an air-liquid interface (ALI) and infected 
with a PCD clinical NTHi isolate. In the present study, we used the ALI-epithelial cell NTHi co-
culture model [22] to more extensively investigate: 1) airway cell responses to NTHi, 
including NO production, and 2) the ability of a biofilm-targeted NO-donor to augment 
antibiotic treatment of NTHi. 
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Materials and Methods 
 
Study participants 
 
 We recruited 15 patients with a diagnosis of PCD, according to the 2009 European 
guidelines [23], 10 healthy volunteers and 9 patients with respiratory symptoms not caused 
by PCD (Supplementary Table 1).  We have previously published details of the diagnostic 
methods undertaken at our national PCD Centre [24]. The study gained UK National Health 
Service Research Ethics approval (06/Q1702/109 and 08/H0502/126) and we obtained 
written, informed consent.  
 
Culture and biofilm development by clinical NTHi isolates from PCD patients 
 
NTHi isolates from 4 paediatric PCD patients (HI1-HI4) were sub-cultured from frozen-stocks 
[25] and verified by Gram stain, V and X diagnostic disc testing, and polymerase chain 
reaction [6].  NTHi was cultured in brain heart infusion medium supplemented with hemin 
and nicotinamide adenine dinucleotide (sBHI) at 37
o
C to OD600 0.1 (~2x10
8
 CFUs/mL for all 
strains tested) [25]. Biofilm growth was determined in vitro in triplicate experiments by 
crystal violet (CV) staining and colony forming unit (CFU) counts on chocolate blood agar 
(CBA) [26], [27] and by scanning electron microscopy (SEM) and confocal microscopy using 
fluorescence in situ hybridization (FISH) [7], [28].  
 
Epithelial cell and NTHi co-culture model 
 
Detailed information regarding epithelial cell recovery and subsequent analysis is available 
in the supplementary material and has been published elsewhere.  Briefly, primary human 
nasal epithelial cells were cultured at an ALI until differentiated and ciliated [29], [30]. We 
used ALI-cultured cells within 1 month. NTHi was co-cultured on the apical surface of 
epithelial cells from 5 PCD and 9 non-PCD subjects and compared with 5 non-infected non-
PCD controls. We inoculated approximately 1x10
8
 CFUs/mL in 500 μL antibiotic-free ALI-
medium (multiplicity of infection 100) onto ALI-cultured cells on transwell membranes. Co-
cultures were incubated at 37
o
C/5% CO2 for 72 hours with daily medium changes and 
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washed with Hanks’ Balanced Salt Solution (HBSS) to remove non-adherent bacteria prior to 
analyses [25].  
 
Trans-epithelial electrical resistance (TEER) was measured daily and background subtracted 
to confirm epithelial integrity (EVOM 2 epithelial voltohmmeter, World Precision 
Instruments, US) [31]. Ciliary beat frequency (CBF) and the percentage area of motile to 
non-motile cilia on ALI-cultured cells before and during NTHi co-culture was measured by 
whole field Fast Fourier Transform (FFT) analysis (ImageJ https://imagej.net/ with an in-
house written plugin) of high-speed video microscopy videos.  Briefly, samples were imaged 
at 37
o
C using an inverted Olympus IX71 microscope with x40 objective lens (Olympus, UK) (1 
field = 90 x 95 µm) and a PC2 Photron FASTCAM high-speed video recorded ciliary 
movement at 250 frames per second (fps) [29].    
 
Characterisation of NTHi on ciliated airway cells 
 
Bacteria and epithelial cells were scraped from transwell membranes into sBHI, serially 
diluted, plated onto CBA and incubated at 37 
o
C/5% CO2 before CFU enumeration (triplicate 
experiments). We also identified NTHi on ALI-culture samples using confocal microscopy by 
fluorescence in situ hybridisation (FISH) with the Hinf 16S probe [6], [7] and β-tubulin in cilia 
co-labelled by immunofluorescence [32]. Consecutive fields across the membrane diameter 
were imaged using an SP5 confocal laser scanning microscope (Leica Microsystems, UK) and 
NTHi volume per field was calculated by Volocity 3D image analysis software (version 6.0.1, 
PerkinElmer, UK).  Selected transwell membranes were removed and processed and imaged 
using an FEI Quanta 200 Scanning Electron Microscope (FEI, NL) [25], [28]. 
 
Cytokine and LL-37 responses to NTHi infection 
 
Baso-lateral medium from ALI-cultures was frozen before inoculation and then daily 
following co-culture with NTHi. We measured FGF-β, G-CSF, GM-CSF, IL-6, IL-1Rα, MCP-1, 
MIP-1α, TNF-α and VEGF by Fluorokine® Human MultiAnalyte Profiling (MAP) assay with 
Bio-Plex® 200 Analyser detection (R&D systems®, UK) in supernatants (50 µL per 96-well in 
duplicate) (see supplemental methods) [33].  Interleukin-8 was measured separately by 
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human IL-8 DuoSet ELISA kit (DY208, R&D systems®, UK) and HRP substrate was detected by 
ThermoMax Microplate Reader (Molecular Devices, US) as per manufacturer’s instructions.  
 
Apical supernatants (100 µL PBS) from ALI-cultured cells were frozen before co-culture and 
then daily following NTHi inoculation. Samples were dotted onto nitrocellulose membranes 
and immunolabelled overnight (4 
o
C) with 1:1,000 rabbit anti-LL-37 antibody (AB64892, 
Abcam®) followed by 1:10,000 horseradish peroxidase (HRP) conjugated goat anti-rabbit 
secondary antibody.  After washes Immuno-star™ Luminol chemiluminescent substrate was 
detected using a VersaDoc
TM
 Imager and quantified by Quantity One®v4.6.9 software (Bio-
Rad Laboratories, UK).  LL-37 concentrations (duplicate experiments) were compared to a 
standard curve from serially diluted recombinant LL-37 peptide (AB140725, Abcam®).  
 
Nitric oxide production by airway epithelial cells and treatment with exogenous NO  
 
Transwell membranes of live ALI-cultured epithelial cells were treated with 10 µM 4-amino-
5-methylamino-2’,7’-difluorofluorescein diacetate (DAF-FM) to assess the presence of NO 
[34].  Immunofluorescence labelling was used to localize NO synthase (NOS) (neuronal 
(nNOS), inducible (iNOS) and endothelial (eNOS) isoenzymes in fixed epithelial cell cultures 
[32] using confocal microscopy. 
 
ALI-cultured epithelial cell-NTHi co-cultures (72 hour) were washed with HBSS to remove 
non-adherent bacteria [25] and then treated with either 4 mg/mL azithromycin, 50 µM 
cephalosporin-3’-diazeniumdiolate NO donor prodrug PYRRO-C3D, or with a combination of 
both azithromycin and PYRRO-C3D for 2 hours. All treatments were prepared in HBSS with 
1% DMSO (also used as the untreated control), and NTHi CFUs were enumerated on CBA as 
above (n=4) [25].  
 
Statistical methods 
 
Student t and Mann Whitney U tests were performed using Graphpad Prism® software 
(version 6.0a, 2012, Graphpad Software Inc.). The Sidak-Bonferroni method was used to 
adapt P values for multiple comparison t-tests. P<0.05 demonstrated statistical significance.  
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Results  
 
Study participants 
 
Demographic and clinical details of the 15 PCD and 19 non-PCD participants are presented 
in Table 1.  All PCD patients exhibited abnormal ciliary function (see Supplementary Table 
1). 
 
Biofilm development by clinical NTHi isolates from PCD patients  
 
We assessed the ability of 4 PCD NTHi isolates to form biofilms by standard assays (CV, CFU 
counts) and by SEM and confocal microscopy using the Hinf-specific 16S FISH probe 
(supplementary methods) (Figure 1A-F). Clinical isolates (HI3 and HI4), from children who 
repeatedly cultured NTHi over 4-years, demonstrated biofilm development with significantly 
greater CV staining of exopolymeric matrix compared with isolates from children culturing 
NTHi for the first time (HI1 and HI2) (Figure 1A).  However CFU counts were not significantly 
different between isolates (Figure 1B). Isolate HI4 was used for future experiments. 
 
Epithelial cell and NTHi co-culture  
 
NTHi adhered to ciliated airway epithelial cells from both PCD and non-PCD patients. At 72 
hours, however, there was significantly more viable NTHi 3.8x10
6 
CFUs (±7.5x10
5
) on PCD 
epithelia compared to 2.0x10
6 
CFUs (±4.8x10
5
) on non-PCD epithelia (P<0.05) (Figure 2A), in 
agreement with SEM data (Figure 2B and C).  PCD cells harboured discrete adherent 
aggregates of bacterial cells (biofilms) (Figure 2B) in contrast to the singularly distributed 
NTHi bacterial cells on non-PCD epithelial cells (Figure 2C).  
We imaged co-cultures by confocal microscopy using a combination of FISH to label NTHi 
and an anti-β-tubulin antibody to label cilia. Orthogonal section image analysis of confocal 
microscope Z-stacks showed that the mean (±SEM) NTHi biomass volume (per field of view) 
was 4 times greater on PCD ALI-cultured epithelia (710 μm
3
±150) compared to non-PCD 
primary cell ALI-cultures (160 μm
3
±20) (P<0.001) (Figure 2D).  Aggregated NTHi were 
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evident in biofilms on PCD primary cell epithelia that had dysfunctional or static cilia (Figure 
2E). In contrast there was less NTHi labelling on non-PCD epithelia with normally functioning 
cilia (Figure 2F).   
 
PCD cells showed either static (n=4) or slow dyskinetic (n=1) cilia. The CBF of non-PCD 
epithelial cells remained within normal ranges (11-20 Hz) throughout the 72 hours of NTHi 
co-culture indicating that NTHi did not impair ciliary motility (Figure 3A). Ciliation of ALI-
cultured epithelial cells was comparable between PCD and non-PCD, as observed by light 
microscopy and SEM (Figure 3B).  The percentage area of motile cilia per field of view on 
non-PCD ALI-cultured cells did not change during the co-culture period on non-PCD airway 
cells (Figure 3C). TEER was used to measure epithelial cell barrier function before and after 
apical NTHi inoculation onto ciliated ALI-cultured primary airway cells. The TEER plateau 
reached prior to NTHi infection was the same for PCD and non-PCD cells and was 
maintained for 72 hours in co-culture, demonstrating epithelial integrity (p values ranged 
from 0.35 to 0.93) (Figure 3D). 
 
Cytokine and LL-37 responses to NTHi infection  
 
The mean (±SEM) concentration of cationic LL-37 peptide secreted from epithelial cell ALI-
cultures peaked 24 h following NTHi inoculation, where an 8.8 fold (±2.9) increase in PCD 
and 3.8 fold (±0.6) increase in non-PCD samples was observed, but values remained within 
group variation at baseline and after inoculation (Figure 4A and B). The levels of FGF-β, G-
CSF, GM-CSF, VEGF or IL-1Ra, IL-6, IL-8, MCP-1, MIP-1α and TNF-α in basolateral medium 
from PCD or non-PCD cells, sampled before or daily during 72 hours of NTHi co-culture 
(Figure 4C) did not significantly differ, indicating that PCD airway cells produced cytokines 
and chemokines comparable to non-PCD cells. These data indicate that PCD and non-PCD 
epithelial cells produce similar defence responses to NTHi. 
 
Nitric oxide production by airway epithelial cells and treatment with exogenous NO  
 
Airway levels of NO are extremely low in patients with PCD [18],[19]. However, we found 
using immunofluorescence labelling of epithelial cells that the nNOS, iNOS and eNOS 
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isoenzymes are present in both ciliated PCD and non-PCD cells (Figure 5).  Additionally, we 
detected NO in PCD and non-PCD ALI-culture samples using DAF-FM, which strongly 
fluoresces in the presence of NO (Figure 5).   
 
We have previously shown that NO modulates NTHi metabolism in vitro [25].  Therefore we 
tested if exogenous NO treatment impacted NTHi growing on ciliated PCD epithelial cells. 
Epithelial cell-NTHi co-cultures were treated with the cephalosporin-3’-diazeniumdiolate NO 
donor prodrug, PYRRO-C3D, which releases NO following activation by β-lactamases [25].  
We found that 4 mg/mL azithromycin treatment, which is in excess of the planktonic 
minimum inhibitory concentration (1 μg/mL), failed to kill biofilm NTHi on PCD epithelial 
cells.  In contrast, when PYRRO-C3D was used alongside azithromycin, NTHi viability 
decreased nearly 3-logs (Figure 6C).  These results suggest that NTHi in biofilms on PCD 
ciliated epithelial cells are tolerant of antibiotic treatment and that tolerance was abrogated 
by β-lactamase-mediated delivery of NO from the prodrug to NTHi.  
 
 
 
 
Discussion 
 
Our principal finding was that NTHi formed adherent biofilms on ALI-cultured PCD ciliated 
airway cells significantly more than on non-PCD controls over 72 hours of co-culture, with 
the only attributable difference being ciliary dysfunction of PCD samples. Since host-
pathogen interactions have not been widely studied in the context of PCD, these results are 
novel.  NTHi is prevalent in PCD and other diseases in children associated with impaired 
mucociliary clearance, such as CF [35] and chronic OM [36].  Whilst NTHi biofilm 
development features in the pathophysiology of chronic or recurrent respiratory infections 
in both CF and chronic OM [6], [4, 13], little is known about NTHi infection in PCD. We 
hypothesized that abnormal ciliary motility on airway epithelial cells from PCD patients 
might be permissive for NTHi colonization and biofilm development. To our knowledge, our 
polarized airway epithelial ALI-culture infection model is the first to examine the effects of 
NTHi on primary ciliated airway cells from PCD patients and non-PCD donors. Biofilm 
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development was previously demonstrated with NTHi isolates from young CF patients using 
Calu-3 cell co-cultures [11]. However, because Calu-3 cells do not ciliate, this model did not 
assess the role of cilia in NTHi adherence and biofilm development [37].  
 
We compared PCD and non-PCD epithelial cell responses, including secreted inflammatory 
and antimicrobial proteins and epithelial integrity, ciliation and ciliary function following 
NTHi co-culture. Cytokine production, including pro-inflammatory cytokines and 
chemokines involved in leukocyte recruitment, and secreted levels of the antimicrobial 
peptide LL-37, were commensurable between PCD and non-PCD co-cultures.  Epithelial 
integrity was also comparable in airway epithelial cells co-cultured with NTHi.  Although all 
PCD ALI-cultured epithelial cells had dysfunctional ciliary movement, in contrast to the 
normally functioning non-PCD epithelial cells (see supplementary table), the total ciliation 
pre-infection was similar, as demonstrated by SEM and immuno-fluorescent labelling of β-
tubulin on cilia using confocal microscopy. Importantly, NTHi infection did not adversely 
affect normal ciliary function (CBF and percentage area of motile cilia) on non-PCD ALI-
cultured airway cells over the experimental period.  Taken together, we found the only 
difference between PCD and non-PCD was in ciliary motility, supporting the hypothesis that 
abnormal ciliary function in PCD increases the risk of NTHi biofilm development.   
 
PCD patients exhibit abnormally low airway (particularly nasal) NO levels, the causes of 
which are still being debated [18]. Previously it was found that ALI-cultured PCD primary 
epithelial cells fail to increase NO levels early after infection with S. pneumoniae, suggesting 
that NO biosynthesis and iNOS induction was abnormal in PCD epithelial cells [20].  In 
contrast, the work herein extends our previous study and demonstrates that NO 
biosynthesis is similar in PCD and non-PCD epithelial cells, both constitutively and following 
NTHi infection [22].  We have now also assessed NO levels using complementary methods 
and show that PCD and non-PCD cells exhibit comparable NO biosynthesis and NOS 
isoenzyme expression that co-localises with the cilia marker β-tubulin, during co-culture. 
These studies support our previous data showing that PCD epithelial cells are capable of 
biosynthesising NO.  Primary epithelial cell NO responses may, however, vary with the type 
of bacteria, and notably the PCD NTHi isolate did not induce the cytotoxic effects observed 
with S. pneumoniae  [38].  
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Our results indicate that NTHi is present in matrix-enclosed aggregates adherent to 
polarised ciliated PCD epithelial cells [8]. Biofilm development is well known to reduce the 
efficacy of antibiotic therapy. Our data indicate that NTHi biofilms on airway epithelial cell 
cultures were tolerant of azithromycin treatment that easily kills planktonic NTHi [25], as it 
was ineffective in reducing NTHi viability.  In contrast, co-administration of azithromycin 
with the novel pro-drug PYRRO-C3D, designed to target NO release specifically to bacteria 
following β-lactamase activation, reduced NTHi viability by nearly 3-logs on PCD epithelial 
cells. These results support recent studies with S. pneumoniae [28] and NTHi [25] showing 
that NO plays a role in modulating metabolic activity in these respiratory bacteria, resulting 
in increased antibiotic sensitivity. Importantly, our airway epithelial cell co-culture model 
permitted the translational investigation of anti-NTHi biofilm treatments in a physiologically 
relevant context with human primary cells. These results suggest that adjunctive exogenous 
NO therapy administered in combination with antibiotics to treat infections warrants 
further investigation. 
 
This study has some limitations. First, because PCD cases are rare (≈1:10,000), the co-culture 
experiments are challenging to replicate in high numbers. Secondly, we examined a limited 
number of clinical NTHi isolates in co-cultures.  Thirdly, our studies focused on epithelial 
cells and did not investigate other innate cell responses that are important in host defences 
to NTHi, or may contribute to disease progression. Despite these limitations, our studies 
suggest that NTHi biofilms play a role in the chronicity of respiratory infections in PCD and 
provide hypothesis-driven research questions for further work assessing mechanisms of 
pathogenesis. 
 
In summary, this study reports key observations regarding NTHi infection of primary ciliated 
epithelial cells from PCD patients.  Firstly, abnormal ciliary function in PCD appears to be 
more permissive for NTHi biofilm development than non-PCD airway cells that have normal 
motility.  Secondly, ALI-cultured primary airway cells from PCD patients appear to be 
competent in several defensive responses following NTHi infection, exhibiting comparable 
cytokine and LL-37 production with non-PCD airway cells. Thirdly, although nasal NO levels 
are abnormally low in most cases of PCD, ALI-cultured airway cells from PCD patients 
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produced similar levels of NO following NTHi co-culture compared to non-PCD cells. 
Fourthly, this study demonstrates that our co-culture model provided a robust assay to 
investigate anti-infective treatments.  Finally, we show that targeted exogenous NO 
enhanced antibiotic killing of NTHi in biofilms growing on PCD epithelia, suggesting a novel 
therapeutic approach for NTHi infection in PCD.   
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Figure legends 
 
Figure 1: Biofilm formation by PCD NTHi isolates (HI1-4).  Bar charts show the mean (±SEM) 
optical densities (OD600) of crystal violet staining (A) and mean (±SEM) log biofilm colony 
forming unit counts (CFUs/cm
2
) (B) for PCD-clinical NTHi isolates (HI1-4) grown for 72 hours 
(*p<0.05). Scanning electron micrographs (x4000) (C, D) highlight bacterial aggregates and 
exopolymeric matrix for HI1 and HI4. Confocal micrographs (E, F) depict representative 
maximum projections (of Z-stacks) and orthogonal sections (x/z right and y/z bottom 
images) of 72 h HI1 and HI4 biofilms hybridized with the CY3-labelled H. influenzae-specific 
FISH probe (green). Scale bars = 10 µm (C, D) 40 µm (E, F). 
 
Figure 2: Characterisation of NTHi co-cultured with air-liquid interface (ALI) differentiated 
and ciliated airway epithelial cells. Graph A depicts the mean (±SEM) log biofilm CFUs/cm
2
 
after 72 h of NTHi co-culture on ALI ciliated PCD (n=5), and non-PCD (n=9) epithelial cells 
(*p<0.05). Representative scanning electron micrographs (x4000) (B and C) demonstrate 
increased bacterial aggregates and exopolymeric matrix formation (arrows) on PCD ALI-
cultured ciliated epithelial cells in contrast to non-PCD cells. NTHi co-cultured on ALI ciliated 
PCD and non-PCD epithelial cells were labelled for confocal analysis. Bacterial cells were 
labelled with the CY3-H. influenzae-specific FISH probe (green), cilia were labelled with anti-
β-tubulin antibody (red) and nuclei were counterstained with SYTOX blue (blue). Graph D 
shows the mean (±SEM) biofilm volume (FISH probe labelling) per field of view (determined 
by Volocity software analysis of confocal microscopy z-stacks) on PCD versus non-PCD 
ciliated ALI-cultures (*p<0.05). Confocal micrographs E and F are represented as 3D opacity 
views of ciliated PCD (E), and non-PCD (F) cells co-cultured for 72 h with NTHi.  Scale bars = 
20 µm. 
 
Figure 3: Comparison of percent ciliation, ciliary function and trans-epithelial electrical 
resistance (TEER) in PCD and non-PCD ALI-cultured airway epithelial cells, and 
characterisation of the effect of NTHi co-culture on cilia. Graph A demonstrates mean 
(±SEM) CBF (in Hz) of PCD (n=4 static cilia and n=1 slow dyskinetic cilia) and non-PCD (n=9) 
measured before (baseline) and daily during 72 h of NTHi co-culture, compared to 
uninfected non-PCD controls (n=5). The normal CBF range is 11-20 Hz at the Southampton 
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PCD Centre and infection did not modify CBF in any group (A). Graph B shows the mean 
(±SEM) percentage ciliation corresponding to coverage of β-tubulin immuno-labelled cilia on 
differentiated ALI-cultures.  Ten randomly selected microscopic fields of view were 
compared per sample and there was no difference in the percentage ciliation between PCD 
(n=5) and non-PCD (n=5) samples. Graph C demonstrates the mean percentage ciliation 
(±SEM) calculated from whole field Fast Fourier Transform (FFT) analysis of ciliary beat 
frequency (CBF) where the ratio of motile to not-motile pixels (15360 data points per total 
field of view from a video recorded at a resolution of 512x480; analysis box size = 4x4 
pixels). The mean (±SEM) percentage ciliation of non-PCD (n=8) ALI-cultured cells before 
(baseline) and daily after NTHi co-culture did not change over 72 hours. Graph D shows the 
mean (±SEM) TEER in Ohms/cm
2
 of NTHi-infected PCD (n=5) and non-PCD (n=9), measured 
before (baseline) and daily during co-culture for 72 h was compared to uninfected non-PCD 
controls (n=5). TEER remained stable and was not significantly different between groups.   
 
Figure 4: PCD and non-PCD epithelial cell LL-37 and cytokine responses to NTHi infection.  
Dot and Whisker plots A and B demonstrate the median (and interquartile range) 
concentration of cationic the antimicrobial peptide, cathelicidin LL-37 (ng/ml), measured in 
the apical supernatants of ALI-cultured epithelial cells from non-PCD (A) and PCD (B) 
patients, before (baseline) or daily after NTHi co-culture for 72 hours. Line graph C depicts 
mean (±SEM) concentrations (pg/ml) of 10 cytokines: basic fibroblast growth factor (FGF-β), 
granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage-colony stimulating 
factor GM-CSF), Interleukin (IL)-6, IL-8, IL-1receptor antagonist (IL-1ra), monocyte 
chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1α (MIP-1α), tumour 
necrosis factor (TNF-α) and vascular endothelial growth factor (VEGF) in the basolateral 
medium of PCD (n=5) and non-PCD (n=9) epithelial cell ALI cultures before (baseline) and 
daily after NTHi co-culture for 72 hours.  (*p<0.05, **p<0.01, ***p<0.001). 
 
Figure 5: Nitric Oxide Synthase (NOS) isoenzymes and Nitric Oxide (NO) were compared 
between ciliated PCD and non-PCD airway epithelial cells cultured at ALI.  Representative 
micrographs of ALI-differentiated epithelial cells show fluorescent labelling with antibodies 
to neuronal NOS (A, D), inducible NOS (B, E) and endothelial NOS (C, F) and an Alexafluor488 
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conjugated secondary antibody (green) in non-PCD (A-C) and PCD (D-F) subjects (n=3 
repeats per group). As a negative control primary antibodies were omitted and confirmed 
that there was no non-specific secondary antibody labelling in non-PCD ALI-cultured 
epithelium (G).  Representative micrographs show the presence of NO by DAF-FM labelling 
(green) in 1 non-PCD (H) and in 2 PCD (I, J) subjects (n=4 non-PCD and n=3 PCD subjects 
were tested in total).  There was no appreciable difference in NOS isoenzyme or DAF-FM 
labelling between non-PCD and PCD ALI-cultures.  Very low background auto-fluorescence 
can be seen in an untreated human bronchial epithelial cell line (16HBE) negative control 
(K). Cell nuclei were stained with Hoechst (red) (B, C, E-G) and cilia were co-labelled with an 
anti-β-tubulin antibody (shown in red) (A, D). Merged maximum projections from confocal 
(A, D, H-K) or epifluorescent (B, C, E-G) microscope images using 100x or 40x objectives (40 
µm scale bars).  
 
Figure 6: Treatment of PCD ALI-differentiated airway epithelial cells with antibiotic and NO 
donor prodrug. The graph shows mean (±SEM) log biofilm colony forming unit counts 
(CFUs/cm
2
) for adherent (biofilm) NTHi-co-cultured for 72 hours on PCD airway epithelial 
cells that were cultured and ciliated at ALI (n=4). Co-cultures were incubated for 2 hours 
either, without (control) or with, NO donor prodrug PYRRO-C3D (50 µM), 4 mg/mL 
azithromycin, or both.  NTHi viability was decreased nearly 3 logs by PYRRO-
C3D/azithromycin treatment.  (*p<0.05). 
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Figure 2: Characterisation of NTHi co-cultured with air-liquid interface (ALI) differentiated and ciliated airway 
epithelial cells. Graph A depicts the mean (±SEM) log biofilm CFUs/cm2 after 72 h of NTHi co-culture on ALI 
ciliated PCD (n=5), and non-PCD (n=9) epithelial cells (*p<0.05). Representative scanning electron 
micrographs (x4000) (B and C) demonstrate increased bacterial aggregates and exopolymeric matrix 
formation (arrows) on PCD ALI-cultured ciliated epithelial cells in contrast to non-PCD cells. NTHi co-cultured 
on ALI ciliated PCD and non-PCD epithelial cells were labelled for confocal analysis. Bacterial cells were 
labelled with the CY3-H. influenzae-specific FISH probe (green), cilia were labelled with anti-β-tubulin 
antibody (red) and nuclei were counterstained with SYTOX blue (blue). Graph D shows the mean (±SEM) 
biofilm volume (FISH probe labelling) per field of view (determined by Volocity software analysis of confocal 
microscopy z-stacks) on PCD versus non-PCD ciliated ALI-cultures (*p<0.05). Confocal micrographs E and F 
are represented as 3D opacity views of ciliated PCD (E), and non-PCD (F) cells co-cultured for 72 h with 
NTHi.  Scale bars = 20 µm.  
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Figure 3: Comparison of percent ciliation, ciliary function and trans-epithelial electrical resistance (TEER) in 
PCD and non-PCD ALI-cultured airway epithelial cells, and characterisation of the effect of NTHi co-culture 
on cilia. Graph A demonstrates mean (±SEM) CBF (in Hz) of PCD (n=4 static cilia and n=1 slow dyskinetic 
cilia) and non-PCD (n=9) measured before (baseline) and daily during 72 h of NTHi co-culture, compared to 
uninfected non-PCD controls (n=5). The normal CBF range is 11-20 Hz at the Southampton PCD Centre and 
infection did not modify CBF in any group (A). Graph B shows the mean (±SEM) percentage ciliation 
corresponding to coverage of β-tubulin immuno-labelled cilia on differentiated ALI-cultures.  Ten randomly 
selected microscopic fields of view were compared per sample and there was no difference in the percentage 
ciliation between PCD (n=5) and non-PCD (n=5) samples. Graph C demonstrates the mean percentage 
ciliation (±SEM) calculated from whole field Fast Fourier Transform (FFT) analysis of ciliary beat frequency 
(CBF) where the ratio of motile to not-motile pixels (15360 data points per total field of view from a video 
recorded at a resolution of 512x480; analysis box size = 4x4 pixels). The mean (±SEM) percentage ciliation 
of non-PCD (n=8) ALI-cultured cells before (baseline) and daily after NTHi co-culture did not change over 72 
hours. Graph D shows the mean (±SEM) TEER in Ohms/cm2 of NTHi-infected PCD (n=5) and non-PCD 
(n=9), measured before (baseline) and daily during co-culture for 72 h was compared to uninfected non-
PCD controls (n=5). TEER remained stable and was not significantly different between groups.    
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Figure 4: PCD and non-PCD epithelial cell LL-37 and cytokine responses to NTHi infection.  Dot and Whisker 
plots A and B demonstrate the median (and interquartile range) concentration of cationic the antimicrobial 
peptide, cathelicidin LL-37 (ng/ml), measured in the apical supernatants of ALI-cultured epithelial cells from 
non-PCD (A) and PCD (B) patients, before (baseline) or daily after NTHi co-culture for 72 hours. Line graph 
C depicts mean (±SEM) concentrations (pg/ml) of 10 cytokines: basic fibroblast growth factor (FGF-β), 
granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage-colony stimulating factor GM-CSF), 
Interleukin (IL)-6, IL-8, IL-1receptor antagonist (IL-1ra), monocyte chemotactic protein-1 (MCP-1), 
macrophage inflammatory protein-1α (MIP-1α), tumour necrosis factor (TNF-α) and vascular endothelial 
growth factor (VEGF) in the basolateral medium of PCD (n=5) and non-PCD (n=9) epithelial cell ALI cultures 
before (baseline) and daily after NTHi co-culture for 72 hours.  (*p<0.05, **p<0.01, ***p<0.001).  
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Figure 5: Nitric Oxide Synthase (NOS) isoenzymes and Nitric Oxide (NO) were compared between ciliated 
PCD and non-PCD airway epithelial cells cultured at ALI.  Representative micrographs of ALI-differentiated 
epithelial cells show fluorescent labelling with antibodies to neuronal NOS (A, D), inducible NOS (B, E) and 
endothelial NOS (C, F) and an Alexafluor488 conjugated secondary antibody (green) in non-PCD (A-C) and 
PCD (D-F) subjects (n=3 repeats per group). As a negative control primary antibodies were omitted and 
confirmed that there was no non-specific secondary antibody labelling in non-PCD ALI-cultured epithelium 
(G).  Representative micrographs show the presence of NO by DAF-FM labelling (green) in 1 non-PCD (H) 
and in 2 PCD (I, J) subjects (n=4 non-PCD and n=3 PCD subjects were tested in total).  There was no 
appreciable difference in NOS isoenzyme or DAF-FM labelling between non-PCD and PCD ALI-cultures.  Very 
low background auto-fluorescence can be seen in an untreated human bronchial epithelial cell line (16HBE) 
negative control (K). Cell nuclei were stained with Hoechst (red) (B, C, E-G) and cilia were co-labelled with 
an anti-β-tubulin antibody (shown in red) (A, D). Merged maximum projections from confocal (A, D, H-K) or 
epifluorescent (B, C, E-G) microscope images using 100x or 40x objectives (40 µm scale bars).  
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Supplementary materials and methods 
 
 
Primary airway epithelial cell sampling 
 
The patients and healthy samples were obtained between 2012 and 2015.  Information on 
the PCD and respiratory control patients and healthy volunteers is summarised in 
Supplementary Table 1.  The clinical history of PCD patients is summarised in Table 1.  We 
performed 2 nasal brushings per PCD patient or healthy volunteer to obtain primary human 
airway epithelial cells, using 2 mm diameter cytology brushes (ConMed, Linvatec, UK).  
Brushes were placed into 1.5 ml Medium 199 (Gibco, Life Technologies, UK) and cells 
dislodged by vigorous pipetting. Cells were pelleted by centrifugation at 1,400 rpm (using a 
Jouan CR312 centrifuge) for 5 minutes.   
 
Air-liquid interface culture 
 
Costar™ culture-ware (Fisher Scientific, ThermoFisher Scientific, UK) was pre-coated with 
300 mg/ml PureCol (Nutacon, NL) before use. Cells were re-suspended in 1 ml bronchial 
epithelial growth medium (BEGM) supplemented with Clonetics™ SingleQuots (Lonza, UK) 
and additional 50 Units/ml penicillin and 50 µg/ml streptomycin (Gibco, Life Technologies, 
UK), and 20 Units/ml nystatin (Sigma-Aldrich, UK) and seeded into wells of 12-well plates. 
Cultures were incubated at 37
o
C (5% CO2, 100% relative humidity) and fed three times per 
week. At approximately 80% confluence the cells were passaged in 0.25% trypsin-EDTA 
solution (5 minutes at 37
o
C), pelleted by centrifugation and resuspended in 5 ml BEGM into 
a T-25 flask. The cells were passaged again, at approximately 80% confluence,  before the 
pellet was re-suspended in 1 ml air-liquid interface medium (ALI medium) containing a 1:1 
ratio of BEBM:Dulbecco’s modified eagle medium (Gibco, Life Technologies, UK) 
supplemented with growth Clonetics™ SingleQuots (using only 1/5th volume of the hEGF 
solution), antibiotics and anti-fungal additives.  Cells (~500,000 per 0.5 ml) were seeded 
submerged into 12-well Costar Transwell inserts and when confluent taken to an air-liquid 
interface (ALI). At ALI the cells were fed baso-laterally with ALI medium, supplemented with 
additional 100 nM retinol (Sigma-Aldrich, UK) to promote basal epithelial cell differentiation 
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to a ciliated columnar cell phenotype (approximately 3 weeks).  ALI-culture ciliation was 
confirmed by light microscopy and ALI-cultures used when cells were ciliated maximally 
(variable coverage). Polarized ciliated epithelial cells from PCD patients or non-PCD 
volunteers were cultured for two days at ALI in ALI-medium without antibiotic or anti-fungal 
treatment prior to NTHi co-culture. 
 
Characterisation of NTHi on ciliated airway cells 
Fluorescence in situ hybridization (16S rRNA FISH) was performed as previously described 
using the H. influenzae 16S ribosomal probe sequence: Hinf Cy3 labeled (Integrated DNA 
Technologies Inc, Lueven, Belgium) 5’- CCGCACTTTCATCTCCG-3’ (16S [185-202]).  ALI-
cultured specimens were fixed with fresh 4% paraformaldehyde in HBSS followed by washes 
with HBSS and HBSS-ethanol (1:1), with subsequent 3-minute incubations in 80% and 100% 
ethanol.  Cilia on epithelial cells were specifically immuno-labelled using an anti-β-tubulin 
antibody so that the localisation of FISH-labelled NTHi could be judged in proximity to cilia.  
Samples were rinsed with sterile PBS and blocked with (20% Newborn calf serum in DMEM, 
with 10% BSA and 0.05% Triton X) for 30 min, rinsed, and incubated with the T5293 anti-β-
tubulin monoclonal antibody (Sigma-Aldrich, UK) (diluted 1:2,000 in blocking buffer) to 
specifically label cilia.  Samples were washed 3 times before incubation for 90 minutes with 
the secondary Alexa Fluor® 594 chicken anti-mouse IgG antibody (A21201, Molecular 
Probes®, Life Technologies, UK).  Epithelial cell nuclei were counterstained for 30 minutes 
with 4',6-diamidino-2-phenylindole (DAPI) (Invitrogen, Life Technologies, UK) diluted 1:360 
in 1x PBS before being washed in 1xPBS and mounted on glass slides. Samples were 
analysed by confocal microscopy (SP5, Leica Microsystems, UK) at x400 magnification and 
every consecutive field of view was assessed across the width of the membrane.  The 
volume of adherent NTHi bacterial micro-colonies on the epithelial cell layers were 
calculated by Volocity 3D image analysis software (version 6.0.1, PerkinElmer, UK). 
 
Cytokine and LL-37 responses to NTHi infection 
 
Baso-lateral medium from ALI-cultures was frozen before inoculation and daily following co-
culture with NTHi. We measured basic fibroblast growth factor (FGF-b), granulocyte- and 
granulocyte-macrophage- colony stimulating factors (G-CSF, GM-CSF), Interleukins- (IL) -6 
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and -8, IL-1receptor antagonist (IL-1ra), monocyte chemotactic protein-1 (MCP-1), 
macrophage inflammatory protein-1α (MIP-1α), tumor necrosis factor (TNF-α) and vascular 
endothelial growth factor (VEGF) by Fluorokine® Human MultiAnalyte Profiling (MAP) assay.  
Cytokine specific antibodies were pre-coated on colour-coded polystyrene beads and 
incubated with thawed supernatants, blank controls and standards (50 µl per 96-well in 
duplicate) for 3 hours.  After washing away unbound sample, a cocktail of biotinylated 
antibodies specific to each cytokine was added for 1 hour, washed, and a streptavidin-
phycoerythrin (streptavidin-PE) conjugate was added for 30 minutes to bind to the 
biotinylated detection antibodies.  All incubations were done at room temperature and in 
the dark on a horizontal orbital shaker (550 rpm).  Unbound streptavidin-PE was finally 
washed away before analysis with a Bio-Plex® 200 Analyser (R&D systems®, UK).  Lasers 
detected bead type and PE signal, directly proportional to the amount of cytokine bound 
[33].  Interleukin-8 was measured separately by human IL-8 DuoSet ELISA kit (DY208, R&D 
systems®, UK).  Basolateral supernatants were diluted 1:5 with 1% bovine serum albumin in 
1x phosphate buffered saline (1% BSA/PBS) and 50 µl incubated at room temperature for 2 
hours in duplicate wells of a 96-well plate (pre-coated overnight at room temperature with 
4 µg/ml monoclonal anti-human IL-8 antibody, washed and blocked in 1% BSA/PBS for 1 
hour at room temperature prior to use) with blank controls and standards.  After washing 
samples, controls and standards were incubated for 2 hours at room temperature with 20 
ng/ml biotinylated goat anti-human IL-8, washed and further incubated for 45 minutes with 
50 µl streptavidin-horseradish peroxidase (HRP). An HRP substrate (50 µl 1:1 solution of 
H2O2 :tetramethybenzidine) was added for 20 minutes and the reaction was stopped by 
addition of 50 µl 2N H2SO4. Light emissions (at a wavelength of 450 nm) were detected in 
wells by a ThermoMax Microplate Reader (Molecular Devices, US) and mean IL-8 
concentration was determined from a standard curve.  
 
Nitric oxide production by airway epithelial cells 
Transwell membranes of live ALI-cultured epithelial cells were treated with 10 µM 4-amino-
5-methylamino-2’,7’-difluororescein diacetate (DAF-FM) [34], which was added directly into 
the basolateral medium (at 37
o
C) of Transwells inserts and imaged by live confocal 
microscopy (SP5 TCS Confocal Microscope, Leica Microsystems UK) to assess the presence 
of NO.  DAF-FM diacetate is weakly fluorescent until the diacetate is cleaved in the presence 
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of NO to produce highly fluorescence DAF-FM.  Images were collected within an hour of 
exposure to DAF-FM diacetate.   
 
 Immunofluorescence labelling was used to localise NO synthase (NOS) isoenzymes, 
(neuronal (nNOS), inducible (iNOS) and endothelial (eNOS) in fixed epithelial cell cultures 
[32] using confocal microscopy. Transwell membranes sections containing cells were fixed in 
ice cold methanol for 10 minutes, blocked for 30 minutes in 1% BSA/PBS containing 
additional 0.05% triton X-100 (blocking buffer).  Calbiochem rabbit anti-human polyclonal 
NOS antibodies (Merck, UK) to nNOS (1414–1434), iNOS (1131–1144) and eNOS (599–913) 
were diluted 1:200 (from 1 mg/ml stock) in blocking buffer and incubated with samples for 
90 minutes at room temperature.  Excess unbound antibody was washed away before 
incubating samples in the dark for a further 90 minutes at room temperature with a 
secondary Alexa488 conjugated goat anti-rabbit antibody (Invitrogen, UK) diluted 1:500 
(from 2 mg/ml stock).  We have previously demonstrated that nNOS co-localised with β-
tubulin labelling in cilia [32].  Therefore for nNOS labelled samples, cilia were co-localised 
with a T5293 monoclonal anti-human β-tubulin antibody (Sigma-Aldrich, UK) diluted 1:2000, 
followed by an Alexa594 conjugated chicken anti-mouse antibody (Molecular Probes, Life 
Technologies, UK) diluted 1:500 (from 2 mg/ml stock) [32].  Cell nuclei were stained for 30 
minutes with 4',6-Diamidino-2-Phenylindole, Dihydrochloride (DAPI) diluted 1:360 in 1x PBS 
(Molecular Probes, Life Technologies, UK).  Slides were mounted under coverslips with 
Mowiol.  Fluorescence labelling was imaged by confocal microscopy. 
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Table 1: Demographics of the PCD, respiratory control and healthy participants. 
 PCD Non-PCD 
Respiratory 
Control 
Healthy  
Number of subjects 15 9 10 
Male n (%) 10 (66.7) 5 (55.6) 3 (30) 
Median age in years (IQR) 16.85 (19.89)  2.9 (4.87) 32.55 (14.96) 
Pulmonary symptoms n (%) 15 (100) 8 (88.9) 0 
Rhinosinusitis n (%) 14 (93.3) 7 (77.8) 0 
Situs abnormality n (%) 9 (60) 1 (11.1)
Δ
 0 
Footnote: 
Δ 
normal diagnostic tests (see Supplementary Table 1, participant 018) 
   
Supplementary Table 1: Diagnostic results for PCD and respiratory control and healthy participants.  
We have indicated which experiments the participants were recruited to (NTHi isolation, co-culture 
(Biofilm CFUs, SEM, FISH, TEER, Cytokines, LL-37), % ciliation by beta-tubulin immunofluorescence 
(IF) or Fast Fourier Transform (FFT) analysis, nitric oxide synthase (NOS) isoenzyme IF, DAF-FM 
labelling of nitric oxide, PYRRO-CD3 treatment).  
 PCD or 
Respiratory 
control or 
Healthy 
Age 
(Years) 
Situs nNO 
(nL/min) 
CBF 
(normal 
range  
11-20 
Hz) 
 
CBP TEM 
defect 
Genotype Experiment(s) 
001 PCD  8 Dextrocardia 9.6 0 Immotile ODA & 
IDA 
ZMYND10 NTHi 
isolation 
002 PCD  15 Heterotaxy 6 0 Immotile    ODA & 
IDA 
DYX1C1 NTHi 
isolation 
003 PCD  10 Normal  15 N/A Predominantly 
immotile 
(some residual 
movement) 
ODA  DNAH5 NTHi 
isolation 
004 PCD  5 Dextrocardia 3 0 Immotile  ODA DNAH5 NTHi 
isolation 
005 PCD  27.97 Normal 77.4 8.67 Asynchronous 
stiff cilia on 2 
separate 
occasions, also 
consistent 
after ALI-
culture 
Normal 
 
Unknown Co-culture, % 
ciliation (by 
beta-tubulin 
IF) 
006 PCD  23.05 Dextrocardia 7.98 N/A Predominantly 
immotile with 
some stiff 
hyperfreq. 
cilia (reduced 
amplitude)    
Normal DNAH11  Co-culture, 
PYRRO-C3D  
007 PCD  14.8 Normal 19.5 0 Immotile  ODA DNAH5 Co-culture, 
NOS 
isoenzymes 
by IF 
008 PCD  16.85 Normal 25.8 0 Immotile  ODA DNAH5 Co-culture 
009 PCD  21.61 Dextrocardia 12.9 N/A Predominantly ODA DNAI1  Co-culture 
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Immotile 
(some residual 
movement)  
NOS 
isoenzymes 
by IF 
010 PCD  47.35 Dextrocardia 12 0 Immotile ODA DNAH5 NOS 
isoenzymes 
by IF, % 
ciliation (by 
beta-tubulin 
IF) 
011 PCD  29.70 Normal 12.6 N/A Predominantly 
stiff moving 
asynchronous 
cilia and 
others 
immotile 
Normal HYDIN % ciliation 
(by beta-
tubulin IF), 
DAF-FM, 
PYRRO-C3D  
012 PCD  7.51 Dextrocardia 3 0 Immotile ODA DNAH5 % ciliation 
(by beta-
tubulin IF), 
DAF-FM 
013 PCD  0.50 Dextrocardia ND 0 Immotile ODA Unknown % ciliation 
(by beta-
tubulin IF), 
DAF-FM 
014 PCD 27.89 Normal 1.6 N/A Predominantly 
stiff moving 
asynchronous 
cilia and 
others 
immotile 
Normal HYDIN PYRRO-C3D 
015 PCD 20.45 Dextrocardia 7.32 N/A Predominantly 
stiff moving 
asynchronous 
cilia and 
others 
immotile 
Normal DNAH11 PYRRO-C3D 
016 Respiratory 
control  
46.18 Normal 277.5 18.47 Normal Normal  ND Co-culture 
017 Respiratory 
control  
2.30 Normal ND 12.2 Normal Normal ND NOS 
isoenzymes 
by IF 
018 
 
Respiratory 
control  
1.49 Dextrocardia ND 15 Normal  ND ND NOS 
isoenzymes 
by IF 
019 Respiratory 
control  
1.80 Normal ND 15.6 Normal ND ND NOS 
isoenzymes 
by IF, % 
ciliation (by 
beta-tubulin 
IF) 
020 Respiratory 
control  
3.02 Normal 52.8 15.5 Normal ND ND % ciliation 
(by beta-
tubulin IF) 
021 Respiratory 
control  
0.19 Unknown ND 14.56 Normal Normal ND % ciliation 
(by beta-
tubulin IF) 
022 Respiratory 
control  
2.91 Normal ND 15.7 Normal Normal ND % ciliation 
(by beta-
tubulin IF), 
DAF-FM 
023 Respiratory 
control  
2.98 Unknown ND 18.7 Normal Normal ND % ciliation 
(by beta-
tubulin IF) 
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024 Respiratory 
control  
10.01 Unknown ND 14.3 Normal Normal ND DAF-FM 
025 Healthy  40.67 ND ND ND ND ND ND Co-culture, % 
ciliation (by 
FFT analysis) 
026 Healthy  29.88 ND ND ND ND ND ND Co-culture, % 
ciliation (by 
FFT analysis) 
027 Healthy  39.47 ND ND ND ND ND ND Co-culture, % 
ciliation (by 
FFT analysis) 
028 Healthy  22.73 ND ND ND ND ND ND Co-culture, % 
ciliation (by 
FFT analysis) 
029 Healthy  33.27 ND ND ND ND ND ND Co-culture, % 
ciliation (by 
FFT analysis) 
030 Healthy  25.04 ND ND ND ND ND ND Co-culture, % 
ciliation (by 
FFT analysis) 
031 Healthy  33.92 ND ND ND ND ND ND Co-culture, % 
ciliation (by 
FFT analysis) 
032 Healthy  23.38 ND ND ND ND ND ND Co-culture, % 
ciliation (by 
FFT analysis) 
033 Healthy 
 
39.93 ND ND ND ND ND ND DAF-FM 
034 Healthy 
 
31.82 ND ND ND ND ND ND DAF-FM 
Key: nasal nitric oxide (nNO); ciliary beat frequency (CBF); ciliary beat pattern (CBP); transmission 
electron microscopy (TEM); ND = test not done, N/A = test none applicable (e.g. CBF result was 
irrelevant due to variable CBP); air-liquid interface (ALI) culture 
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Table 1: Demographics of the PCD, respiratory control and healthy participants. 
 PCD Non-PCD 
Respiratory 
Control 
Healthy  
Number of subjects 15 9 10 
Male n (%) 10 (66.7) 5 (55.6) 3 (30) 
Median age in years (IQR) 16.85 (19.89)  2.9 (4.87) 32.55 (14.96) 
Pulmonary symptoms n (%) 15 (100) 8 (88.9) 0 
Rhinosinusitis n (%) 14 (93.3) 7 (77.8) 0 
Situs abnormality n (%) 9 (60) 1 (11.1)
Δ
 0 
Footnote: 
Δ 
normal diagnostic tests (see Supplementary Table 1, participant 018) 
   
Supplementary Table 1: Diagnostic results for PCD and respiratory control and healthy participants.  
We have indicated which experiments the participants were recruited to (NTHi isolation, co-culture 
(Biofilm CFUs, SEM, FISH, TEER, Cytokines, LL-37), % ciliation by beta-tubulin immunofluorescence 
(IF) or Fast Fourier Transform (FFT) analysis, nitric oxide synthase (NOS) isoenzyme IF, DAF-FM 
labelling of nitric oxide, PYRRO-CD3 treatment).  
 PCD or 
Respiratory 
control or 
Healthy 
Age 
(Years) 
Situs nNO 
(nL/min) 
CBF 
(normal 
range  
11-20 
Hz) 
 
CBP TEM 
defect 
Genotype Experiment(s) 
001 PCD  8 Dextrocardia 9.6 0 Immotile ODA & 
IDA 
ZMYND10 NTHi 
isolation 
002 PCD  15 Heterotaxy 6 0 Immotile    ODA & 
IDA 
DYX1C1 NTHi 
isolation 
003 PCD  10 Normal  15 N/A Predominantly 
immotile 
(some residual 
movement) 
ODA  DNAH5 NTHi 
isolation 
004 PCD  5 Dextrocardia 3 0 Immotile  ODA DNAH5 NTHi 
isolation 
005 PCD  27.97 Normal 77.4 8.67 Asynchronous 
stiff cilia on 2 
separate 
occasions, also 
consistent 
after ALI-
culture 
Normal 
 
Unknown Co-culture, % 
ciliation (by 
beta-tubulin 
IF) 
006 PCD  23.05 Dextrocardia 7.98 N/A Predominantly 
immotile with 
some stiff 
hyperfreq. 
cilia (reduced 
amplitude)    
Normal DNAH11  Co-culture, 
PYRRO-C3D  
007 PCD  14.8 Normal 19.5 0 Immotile  ODA DNAH5 Co-culture, 
NOS 
isoenzymes 
by IF 
008 PCD  16.85 Normal 25.8 0 Immotile  ODA DNAH5 Co-culture 
009 PCD  21.61 Dextrocardia 12.9 N/A Predominantly ODA DNAI1  Co-culture 
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Immotile 
(some residual 
movement)  
NOS 
isoenzymes 
by IF 
010 PCD  47.35 Dextrocardia 12 0 Immotile ODA DNAH5 NOS 
isoenzymes 
by IF, % 
ciliation (by 
beta-tubulin 
IF) 
011 PCD  29.70 Normal 12.6 N/A Predominantly 
stiff moving 
asynchronous 
cilia and 
others 
immotile 
Normal HYDIN % ciliation 
(by beta-
tubulin IF), 
DAF-FM, 
PYRRO-C3D  
012 PCD  7.51 Dextrocardia 3 0 Immotile ODA DNAH5 % ciliation 
(by beta-
tubulin IF), 
DAF-FM 
013 PCD  0.50 Dextrocardia ND 0 Immotile ODA Unknown % ciliation 
(by beta-
tubulin IF), 
DAF-FM 
014 PCD 27.89 Normal 1.6 N/A Predominantly 
stiff moving 
asynchronous 
cilia and 
others 
immotile 
Normal HYDIN PYRRO-C3D 
015 PCD 20.45 Dextrocardia 7.32 N/A Predominantly 
stiff moving 
asynchronous 
cilia and 
others 
immotile 
Normal DNAH11 PYRRO-C3D 
016 Respiratory 
control  
46.18 Normal 277.5 18.47 Normal Normal  ND Co-culture 
017 Respiratory 
control  
2.30 Normal ND 12.2 Normal Normal ND NOS 
isoenzymes 
by IF 
018 
 
Respiratory 
control  
1.49 Dextrocardia ND 15 Normal  ND ND NOS 
isoenzymes 
by IF 
019 Respiratory 
control  
1.80 Normal ND 15.6 Normal ND ND NOS 
isoenzymes 
by IF, % 
ciliation (by 
beta-tubulin 
IF) 
020 Respiratory 
control  
3.02 Normal 52.8 15.5 Normal ND ND % ciliation 
(by beta-
tubulin IF) 
021 Respiratory 
control  
0.19 Unknown ND 14.56 Normal Normal ND % ciliation 
(by beta-
tubulin IF) 
022 Respiratory 
control  
2.91 Normal ND 15.7 Normal Normal ND % ciliation 
(by beta-
tubulin IF), 
DAF-FM 
023 Respiratory 
control  
2.98 Unknown ND 18.7 Normal Normal ND % ciliation 
(by beta-
tubulin IF) 
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024 Respiratory 
control  
10.01 Unknown ND 14.3 Normal Normal ND DAF-FM 
025 Healthy  40.67 ND ND ND ND ND ND Co-culture, % 
ciliation (by 
FFT analysis) 
026 Healthy  29.88 ND ND ND ND ND ND Co-culture, % 
ciliation (by 
FFT analysis) 
027 Healthy  39.47 ND ND ND ND ND ND Co-culture, % 
ciliation (by 
FFT analysis) 
028 Healthy  22.73 ND ND ND ND ND ND Co-culture, % 
ciliation (by 
FFT analysis) 
029 Healthy  33.27 ND ND ND ND ND ND Co-culture, % 
ciliation (by 
FFT analysis) 
030 Healthy  25.04 ND ND ND ND ND ND Co-culture, % 
ciliation (by 
FFT analysis) 
031 Healthy  33.92 ND ND ND ND ND ND Co-culture, % 
ciliation (by 
FFT analysis) 
032 Healthy  23.38 ND ND ND ND ND ND Co-culture, % 
ciliation (by 
FFT analysis) 
033 Healthy 
 
39.93 ND ND ND ND ND ND DAF-FM 
034 Healthy 
 
31.82 ND ND ND ND ND ND DAF-FM 
Key: nasal nitric oxide (nNO); ciliary beat frequency (CBF); ciliary beat pattern (CBP); transmission 
electron microscopy (TEM); ND = test not done, N/A = test none applicable (e.g. CBF result was 
irrelevant due to variable CBP); air-liquid interface (ALI) culture 
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